How Do We Make Choices in Salvage Therapy: Panitumumab, Cetuximab, or Regorafenib?

Overview of attention for article published in Current Colorectal Cancer Reports, September 2013

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 X post from an account with 427 followers.

Congrats Drs Tsvetkova and Asmis for your recent publication on novel agent selection in colorectal cancer http://t.co/0YY5SoCfF2